First Ebola Vaccine Trial Targets Deadly Congo Outbreak

Scientists just gave the first human dose of a vaccine designed specifically for the Bundibugyo Ebola strain—a breakthrough that could save thousands of lives in the Democratic Republic of Congo, where over 1,000 people have already died.

The vaccine went from concept to human trial in just eight weeks.